Medical Devices · Healthcare
Head of Investor Relations
Head of Investor Relations
Integra Lifesciences Holdings Corp (IART)Equibles does not estimate personal net worth.
Get an email with a short summary when Integra Lifesciences Holdings Corp publishes a filing, an earnings call transcript or a press release.
Get IART alertsChris Ward is recorded as Head of Investor Relations at Integra Lifesciences Holdings Corp (IART). Chris Ward has spoken on 14 earnings calls across 1 company, most recently for Integra Lifesciences Holdings Corp on October 21, 2026. Integra Lifesciences Holdings Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Integra Lifesciences Holdings Corp includes Dr. Stuart M. Essig (CEO), Mojdeh Poul (CEO and Board Member), Stuart M. Essig (CEO and Chairman) and 7 others.
“Joining me on the call are Stuart Essick, Chairman and Chief Executive Officer, and Leah Knight, Chief Financial Officer. We issued a press release this morning announcing our third quarter 2026 financial results.”
“Good morning, and thank you for joining the Integra Life Sciences second quarter 2026 earnings conference call. Joining me on the call are Stuart Essick, Chairman, President, and Chief Executive Officer, and Leah Knight, Chief Financial Officer.”
“Good morning, and thank you for joining the Integra Life Sciences' first quarter, 2026 earnings conference call. Joining me on the call are Stuart Essek, Chairman, President, and Chief Executive Officer, and Leah Knight, Chief Financial Officer.”
“Good morning, and thank you for joining the Integral Life Sciences 4th Quarter 2025 Earnings Conference Call. With me on the call are Melissa Pohl, President and Chief Executive Officer, and Leah Knight, Chief Financial Officer.”
“Good morning and thank you for joining the Integra LifeSciences first quarter 2025 earnings conference call. With me on the call are Mojdeh Poul, President and Chief Executive Officer; and Lea Knight, Chief Financial Officer.”
Medical Devices · Healthcare
Head of Investor Relations